ATE520664T1 - Tyrosinkinase-hemmer - Google Patents

Tyrosinkinase-hemmer

Info

Publication number
ATE520664T1
ATE520664T1 AT06785319T AT06785319T ATE520664T1 AT E520664 T1 ATE520664 T1 AT E520664T1 AT 06785319 T AT06785319 T AT 06785319T AT 06785319 T AT06785319 T AT 06785319T AT E520664 T1 ATE520664 T1 AT E520664T1
Authority
AT
Austria
Prior art keywords
tyrosine kinase
kinase inhibitors
inhibitors
tyrosine
kinase
Prior art date
Application number
AT06785319T
Other languages
English (en)
Inventor
Christopher Dinsmore
James Jewell
Jason Katz
Michelle Machacek
Ryan Otte
Jonathan Young
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE520664T1 publication Critical patent/ATE520664T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06785319T 2005-06-23 2006-06-22 Tyrosinkinase-hemmer ATE520664T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69322905P 2005-06-23 2005-06-23
US72906105P 2005-10-21 2005-10-21
US78947306P 2006-04-05 2006-04-05
PCT/US2006/024256 WO2007002258A2 (en) 2005-06-23 2006-06-22 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met

Publications (1)

Publication Number Publication Date
ATE520664T1 true ATE520664T1 (de) 2011-09-15

Family

ID=37595817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06785319T ATE520664T1 (de) 2005-06-23 2006-06-22 Tyrosinkinase-hemmer

Country Status (21)

Country Link
EP (1) EP1896422B1 (de)
KR (1) KR20080018907A (de)
AR (1) AR057377A1 (de)
AT (1) ATE520664T1 (de)
BR (1) BRPI0612518A2 (de)
CR (1) CR9579A (de)
CY (1) CY1112038T1 (de)
DO (1) DOP2006000143A (de)
EC (1) ECSP078017A (de)
IL (1) IL187895A0 (de)
MA (1) MA29643B1 (de)
MX (1) MX2007016533A (de)
NI (1) NI200700318A (de)
NO (1) NO20080417L (de)
NZ (1) NZ563711A (de)
PE (1) PE20070167A1 (de)
PL (1) PL1896422T3 (de)
PT (1) PT1896422E (de)
SI (1) SI1896422T1 (de)
TW (1) TW200738638A (de)
WO (1) WO2007002258A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
US7893081B2 (en) * 2007-12-20 2011-02-22 Merck & Co., Inc. Tyrosine kinase inhibitors
US9238571B2 (en) 2009-09-30 2016-01-19 Merck Sharp & Dohme Limited Formulations for c-Met kinase inhibitors
JP5785171B2 (ja) 2009-09-30 2015-09-24 メルク・シャープ・エンド・ドーム・コーポレイション C−metキナーゼ阻害剤の結晶性塩酸塩
EP2588107A1 (de) 2010-07-01 2013-05-08 Takeda Pharmaceutical Company Limited Kombination aus einem cmet-hemmer und einem antikörper gegen hgf und/oder cmet
ES2764299T3 (es) 2014-12-09 2020-06-02 Inst Nat Sante Rech Med Anticuerpos monoclonales humanos contra AXL
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis
BR112021018168B1 (pt) 2019-03-21 2023-11-28 Onxeo Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer
CA3159348A1 (en) 2019-11-08 2021-05-14 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2286275T3 (es) * 2001-09-19 2007-12-01 Pharmacia Corporation Compuestos de pirazolo sustituidos para el tratamiento de la inflamacion.
WO2003084931A1 (en) * 2002-04-02 2003-10-16 Merck & Co., Inc. 5h-benzo[4,5]cyclohepta[1,2-b]pyridine nmda/nr2b antagonists

Also Published As

Publication number Publication date
NI200700318A (es) 2008-05-23
WO2007002258A2 (en) 2007-01-04
EP1896422B1 (de) 2011-08-17
SI1896422T1 (sl) 2011-11-30
PE20070167A1 (es) 2007-04-16
IL187895A0 (en) 2008-03-20
KR20080018907A (ko) 2008-02-28
PT1896422E (pt) 2011-11-08
PL1896422T3 (pl) 2012-01-31
MA29643B1 (fr) 2008-07-01
WO2007002258A3 (en) 2007-06-07
CR9579A (es) 2008-03-06
NO20080417L (no) 2008-03-18
TW200738638A (en) 2007-10-16
NZ563711A (en) 2010-12-24
AR057377A1 (es) 2007-11-28
CY1112038T1 (el) 2015-11-04
ECSP078017A (es) 2008-01-23
BRPI0612518A2 (pt) 2010-11-23
MX2007016533A (es) 2008-03-06
DOP2006000143A (es) 2007-02-28
EP1896422A2 (de) 2008-03-12

Similar Documents

Publication Publication Date Title
FR21C1019I2 (fr) Inhibiteurs de kinase de type biaryl-meta-pyrimidine
IL280173A (en) Inhibitors of brutons tyrosine kinase
CY2017012I1 (el) Αναστολεις κινασης τυροσινης bruton
EP2040546A4 (de) Tyrosinkinasehemmer
DK1979356T3 (da) Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
NO20082517L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
ATE520671T1 (de) Pyrimidin-harnstoff-derivate als kinase-hemmer
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
DK1704145T3 (da) Selektive kinaseinhibitorer
EP1968950A4 (de) Pyrimidinkinaseinhibitoren
IL186845A0 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
EP1807077A4 (de) Inhibitoren von c-fms-kinase
DE602007008837D1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
BRPI0716781A2 (pt) Inibidores da quinase
ZA200900019B (en) Tyrosine kinase inhibitors
ATE530545T1 (de) Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate
EP1893607A4 (de) Checkpoint-kinasehemmer
DK2035385T3 (da) Inhibitorer af akt (proteinkinase B)
DK1943243T3 (da) Kinase-inhibitorer
ATE433449T1 (de) Kinaseinhibitoren
ATE520664T1 (de) Tyrosinkinase-hemmer
ATE521603T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
ATE472532T1 (de) Oxindole als kinaseinhibitoren
BRPI0719883A2 (pt) Inibidores de quinase
EP1651209A4 (de) Tyrosin-kinase-hemmer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1896422

Country of ref document: EP